Showing 20 of 79 recruiting trials for “paris-trousseau-thrombocytopenia”
V-IMMUNE® for Immune Thrombocytopenia
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, M.D., Hospital of Hematology, Chinese Academy of Medical Sciences📍 7 sites📅 Started May 2025View details ↗
A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric Population With Obesity at Different Biological Maturation States (HIIT-PRO Kids).
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Mar 2025View details ↗
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Jan 2025View details ↗
Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia
A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
Management of Children With Persistent ITP, A Novel Approach
👨⚕️ Mervat M A Youssef, Assistant Professor, Assiut University📍 3 sites📅 Started Jan 2025View details ↗
Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →